Effects on Dementia Caregivers

December 3, 2024 updated by: University of Central Florida

Testing a Strategy to Improve the Effects of Caregiving for Caregivers of Persons with Dementia

The Three Good Things (3GT) is a gratitude list intervention that is empirically supported (Emmons & McCullough, 2003; Seligman et al., 2005) and is a low-cost, easily accessible tool for medical and mental providers to recommend and dementia caregivers to implement independently. Thus, this study aims to investigate the feasibility of use of 3GT in the dementia caregiving population and investigate potential therapeutic mechanisms of the intervention.

Study Overview

Status

Completed

Conditions

Detailed Description

The hypothesis predicts that Caregivers of persons diagnosed with dementia who are randomized into the intervention group (3GT) will report reduced levels of depression, burden, burnout, show an increase in levels of gratitude, increased positive emotion, and increased positive reframing (Brief COPE: Positive Reinterpretation scale and Positive Aspects of Caregiving measure) as compared to baseline levels, and post-follow up assessment in 15 days. The participants will be recruited from local community partners and Amazon MTurk. They will be randomized into 2 groups; one group will be asked to reflect on three good things that happened that day, and the other group will be asked to reflect on early memories. Participants will be reminded via text message daily for 15 days and asked to document their three good things or early memories on a Qualtrics link that will be provided in the text message. Additionally, they will be asked to answer 10 mood-related questions daily. An ANOVA will be used to assess the pre and post intervention differences between groups for depression, burden, burnout, gratitude, positive emotion, and positive reframing. Multilevel modeling will be used to assess the relationships between gratitude and depression at the within-subjects level and then between-subjects by intervention condition. Identified demographic factors will be added to covary at both levels of analysis. Data will be de-identified and stored on a University of Central Florida local hard drive, which requires special permission and password-protected profiles.

Study Type

Interventional

Enrollment (Actual)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Florida
      • Orlando, Florida, United States, 32816
        • University of Central Florida

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Self-identified caregivers of persons with dementia at least 18 years of age
  • Identify English as their primary language
  • Self-report current care for an older adult with dementia identified by a medical professional

Exclusion Criteria:

  • Participants that are currently receiving psychotherapy, have a diagnosis of dementia, and/or severe mental illness
  • Individuals under the age of 18 years old
  • Adults who cannot consent in English
  • Pregnant women and prisoners will not be included in the study.
  • Participants who do not have access to a phone that can not receive text messages will not be able to participate, as equipment will not be provided to Participants.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Intervention Protocol (The 3GT)
Participants will be asked to identify three things that went well that day and their role for this occurring ["What went well today, and what was your role in making it happen?" as adapted from (Sexton & Adair, 2019)]. They will be asked to engage in this exercise for 15 days during the evening.
Participants will be asked to identify three things that went well that day and their role for this occurring ["What went well today, and what was your role in making it happen?" as adapted from (Sexton & Adair, 2019)]. They will be asked to engage in this exercise for 15 days during the evening.
Active Comparator: Control Group
Participants will be asked to reflect on early memories of their life, with no specific prompts provided, for 15 days during the evening. This activity is consistent with prior efficacy studies of 3GT (Seligman et al., 2005).
Participants will be asked to reflect on early memories of their life, with no specific prompts provided, for 15 days during the evening. This activity is consistent with prior efficacy studies of 3GT (Seligman et al., 2005).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
To measure gratitude using The Gratitude Questionnaire (GQ-6)
Time Frame: 6 months
The Gratitude Questionnaire (GQ-6), which is a widely used measure trait gratitude will be used. The GQ-6 is a 6 item self-report questionnaire that assesses gratitude disposition in an individual.
6 months
To measure depressive symptoms using the Center for Epidemiologic Studies Depression Scale (CES-D 10)
Time Frame: 6 months
For this study, the 10-item Center for Epidemiologic Studies Depression Scale (CES-D 10) will be used to measure depressive symptoms
6 months
To measure burnout using The Informal Caregiver Burnout Inventory 10 (ICBI-10)
Time Frame: 6 months
The Informal Caregiver Burnout Inventory 10 (ICBI-10) is a new measure developed to capture burnout specifically in caregivers, aiming to validate prior attempts to modify language in general use burnout measures that typically capture occupational burnout.
6 months
To assess positive emotion using The Positive and Negative Affect Schedule (PANAS)
Time Frame: 6 months
The Positive and Negative Affect Schedule (PANAS) will be utilized to assess positive affect. The PANAS is a 20-item self-report measure assessing two dimensions of affect (positive and negative) utilizing 5-point Likert scale.
6 months
To measure positive reframing using the Brief COPE Inventory: Positive Reinterpretation subscale
Time Frame: 6 months
To measure positive reframing, the Brief COPE Inventory: Positive Reinterpretation subscale will be used (Items 12 and 17), which is a measure that assess different types of coping utilized by individuals in stressful situations.
6 months
To evaluate practical implications of positive reframing using the Positive Aspects of Caregiving measure
Time Frame: 6 months
The Positive Aspects of Caregiving measure is a 9-item self-report scale assessing the positive factors associated with caregiving, utilizing a 5-point Likert scale ranging from 1 ("Disagree a lot") to 5 ("Agree").
6 months
Assess caregiver burden using the Zarit Burden Interview
Time Frame: 6 months
The Zarit Burden Interview, short form (ZBI-SF) will be used to measure participants subjective burden related to their caregiving role.
6 months
To asses ICN1-10 validity, the Burnout Measure, Short (BMS) will be used
Time Frame: 6 months
To provide convergent validity for the use of the ICBI-10 in this sample, the Burnout Measure, Short (BMS) will be used, which is a widely used measure of burnout. The BMS is a 10-item, self-report measure that assess three factors of burnout including physical, emotional and mental exhaustion.
6 months
To measure daily depressive symptoms using the NIH Patient-Reported Outcomes Measurement Information System (PROMIS)
Time Frame: 6 months
4 questions adapted from the The NIH Patient-Reported Outcomes Measurement Information System (PROMIS) short form depression item will be used.
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Nicole McClure, MS, MA, University of Central Florida

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 14, 2023

Primary Completion (Actual)

January 4, 2024

Study Completion (Actual)

January 4, 2024

Study Registration Dates

First Submitted

June 19, 2024

First Submitted That Met QC Criteria

June 19, 2024

First Posted (Actual)

June 25, 2024

Study Record Updates

Last Update Posted (Estimated)

December 6, 2024

Last Update Submitted That Met QC Criteria

December 3, 2024

Last Verified

December 1, 2024

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dementia

Clinical Trials on Intervention Protocol (The 3GT)

Subscribe